MedPath

Effect Of Sodium Thiosulfate On Arterial Stiffness in End-Stage Renal Disease Patients Undergoing Chronic Hemodialysis

Phase 3
Completed
Conditions
ESRD patients undergoing chronic HDPresence of arterial stiffness measured by cfPWV and CAVI methodVascular calcificationInflammation in ESRD patients undergoing chronic HD
ESRD
chronic hemodialysis
arterial stiffness
vascular calcification
sodium thiosulfate
cPWV
CAVI
CT coronary calcium score
Registration Number
TCTR20160814001
Lead Sponsor
Jongkolnee Nidhi foundation Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

1.Age older than 18 years old
2.Dialysis vintage at least 6 months’ duration
3.Hemodialysis frequency 2 or 3 times per week
4.Presence of increased arterial stiffness measured by cfPWV (cfPWV>=10 m/s)
5.Informed consent
6.Can follow the research methodology and follow up regularly

Exclusion Criteria

1.Life expectancy less than 6 months
2.Missing a dialysis session more than twice per month
3.Active malignancy or infection
4.Known pregnancy
5.Recently use of oral or IV corticosteroid therapy within 1 month (dose more than 5 mg of prednisolone or equivalent)
6.Allergy or known sensitivity to sodium thiosulfate
7.Intact PTH more than 9 times of UNL in previous 3 months ( using 2nd generation intact PTH more than 585 pg/ml)
8.Abnormal limb that cannot be measured by cfPWV eg. above or below knee amputation, severe PAD etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Arterial stiffness 24 weeks carotid-femoral pulse wave velocity (cfPWV)
Secondary Outcome Measures
NameTimeMethod
Vascular calcification 24 weeks CT Coronary Artery Calcium score,Inflammatory marker 24 weeks high-sensitivity CRP (hsCRP),Arterial stiffness (BP independent method) 24 weeks Cardio-Ankle Vascular Index (CAVI),Arterial siffness 48 weeks Carotid-femoral pulse wave velocity (cfPWV)
© Copyright 2025. All Rights Reserved by MedPath